Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 5, 2010, Pages 1278-1287

  Marini, R D ^a   Rozet, E ^a   Montes, M L A ^b   Rohrbasser, C ^b   Roht, S ^b   Rheme D ^b   Bonnabry, P ^c   Schappler, J ^d   Veuthey, J L ^d   Hubert, Ph ^a   Rudaz, S ^d  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Department of Information and Communication Technology   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Capillary electrophoresis; Counterfeiting; Drug products; Method comparison; Validation

Indexed keywords

COTRIMOXAZOLE; FUROSEMIDE; QUININE; REAGENT;

ACCURACY; ARTICLE; CALIBRATION; CAPILLARY ZONE ELECTROPHORESIS; COST; DRUG QUALITY; INTERMETHOD COMPARISON; PH; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DETECTOR; RELIABILITY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 77955920696     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.07.026     Document Type: Article

References (47)

1. World Health Organization Counterfeit Medical Products, Report by the Secretariat, Executive Board, 124th Session 2008.
2. World Health Organization Counterfeit Drugs-Guidelines for the Development of Measures to Combat Counterfeit Drugs 1999, WHO, Geneva, pp. 1-62.
3. International Medical Products Anti-Counterfeiting Taskforce, WHO Counterfeiting Drugs Kill, Meeting Report 2008.
4. Deisingh A.K. Pharmaceutical counterfeiting. Analyst 2005, 130:271-279.
5. (July 2010). http://info.france2.fr/monde/Chirac-veut-mobiliser-contre-les-faux-m%25C3%25A9dicaments-57986617.html.
6. Cockburn R., Newton P.N., Agyarko E.K., Akunyili D., White N.J. Correction: the global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med. 2005, e100.
7. WHO Counterfeit Medicines, Fact Sheet 275 July 2010, http://www.who.int/mediacentre/factsheets/fs275/en/print.html.
8. Westenberger B.J., Ellison C.D., Fussner A.S., Jenney S., Kolinski R.E., Lipe T.G., Lyon R.C., Moore T.W., Revelle L.K., Smith A.P., Spencer J.A., Story K.D., Toyler D.Y., Wokovich A.M., Buhse L.F. Quality assessment of Internet pharmaceutical products using traditional and non-traditional analytical techniques. Int. J. Pharm. 2005, 306:56-70.
9. European Commission, 2007, Combating counterfeit & piracy, (July 2010). http://ec.europa.eu/taxation_customs/customs/customs_controls/counterfeit_piracy/combating/index_en.htm.
10. Delavaux J. En Marche, Bimensuel 1410 2009, Le Congo malade de faux médicaments, p. 6.
11. Burns W. Bull. World Health Org. 2006, 84:689-690.
12. International Medical Products Anti-Counterfeiting Taskforce, Principles and Elements for National Legislation Against Counterfeit Medical Products IMPACT General Meeting 2007, pp. 1-13.
13. New FDA Initiative to Combat Counterfeit Drugs 28 February 2009, U.S. Food and Drug Administration, (July 2010). http://www.fda.gov/oc/initiatives/counterfeit/backgrounder.html.
14. 1H NMR and Raman spectroscopy. J. Pharm. Biomed. Anal. 2008, 47:103-113.
15. ® with Raman spectroscopy. J. Pharm. Biomed. Anal. 2008, 46:303-309.
16. Green M.D., Nettey H., Villalva Rojas O., Pamanivong C., Khounsaknalath L., Grande Ortiz M., Newton P.N., Fernández F.M., Vongsack L., Manolin O. Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. J. Pharm. Biomed. Anal. 2007, 43:105-110.
17. ® example. J. Pharm. Biomed. Anal. 2007, 43:1514-1518.
18. ® counterfeits: a comparison of NIR and Raman spectroscopy in combination with chemometrics. J. Pharm. Biomed. Anal. 2008, 47:688-694.
19. Rodionova O.Ye., Houmøller L.P., Pomerantsev A.L., Geladi P., Burger J., Dorofeyev V.L., Arzamastsev A.P. NIR spectrometry for counterfeit drug detection. A feasibility study. Anal. Chim. Acta 2005, 549:151-158.
20. Westenberger B.J., Ellison C.D., Fussner A.S., Jenney S., Kolinski R.E., Lipe T.G., Lyon R.C., Moore T.W., Revelle L.K., Smith A.P., Spencer J.A., Story K.D., Toler D.Y., Wokovich A.M., Buhse L.F. Quality assessment of Internet pharmaceutical products using traditional and non-traditional analytical techniques. Int. J. Pharm. 2005, 306:56-70.
21. Puchert T., Lochmann D., Menezes J.C., Reicha G. Near-infrared chemical imaging (NIR-CI) for counterfeit drug identification. A four stage concept with a novel approach of data processing (Linear Image Signature). J. Pharm. Biomed. Anal. 2010, 51:138-145.
22. Storme-Paris I., Rebiere H., Matoga M., Civade C., Bonnet P.-A., Tissier M.H., Chaminade P. Challenging near infrared spectroscopy discriminating ability for counterfeit pharmaceuticals detection. Anal. Chim. Acta 2010, 658:163-174.
23. Rebiere H., Mazel B., Civade C., Bonnet P.-A. Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography. J. Chromatogr. B 2007, 850:376-383.
24. Schad G.J., Allanson A., Mackay S.P., Cannavan A., Tettey J.N.A. Development and validation of an improved HPLC method for the control of potentially counterfeit isometamidium products. J. Pharm. Biomed. Anal. 2008, 46:45-51.
25. Panusa A., Multari G., Incarnato G., Gagliardi L. High-performance liquid chromatography analysis of anti-inflammatory pharmaceuticals with ultraviolet and electrospray-mass spectrometry detection in suspected counterfeit homeopathic medicinal products. J. Pharm. Biomed. Anal. 2007, 3:1221-1227.
26. Wynia G.S., Windhorst G., Post P.C., Maris F.A. Development and validation of a capillary electrophoresis method within a pharmaceutical quality control environment and comparison with high-performance liquid chromatography. J. Chromatogr. A 1997, 773:339-350.
27. Mayer B.X., Müller M. Long-term analyses with capillary electrophoresis. LC-GC Europe 2001, 2-7.
28. Altria K.D., Hadgett T.A. An evaluation of the use of capillary electrophoresis to monitor trace drug residues following the manufacture of pharmaceuticals. Chromatographia 1995, 40:23-27.
29. Marini R.D., Matthijs N., Vander Heyden Y., Smeyers-Verbeke J., Dehouck P., Hoogmartens J., Silvestre P., Ceccato A., Goedert Ph., Saevels J., Herbots C., Caliaro G., Herráez-Hernández R., Verdú-Andrès J., Campìns-falcó P., Van de Wauw W., De Beer J., Boulanger B., Chiap P., Crommen J., Hubert Ph. Collaborative study on a liquid chromatographic method for the determination of R-timolol and other related substances in S-timolol maleate. Anal. Chim. Acta 2005, 546:182-192.
30. Marini R.D., Groom C., Doucet F.R., Hawari J., Bitar Y., Holzgrabe U., Gotti R., Schappler J., Rudaz S., Veuthey J.-L., Mol R., Somsen G.W., de Jong G.J., Ha P.T.T., Zhang J., Van Schepdael A., Hoogmartens J., Briône W., Ceccato A., Boulanger B., Mangelings D., Vander Heyden Y., Van Ael W., Jimidar I., Pedrini M., Servais A.-C., Fillet M., Crommen J., Rozet E., Hubert Ph. Interlaboratory study of a NACE method for the determination of R-timolol content in S-timolol maleate: assessment of uncertainty. Electrophoresis 2006, 27:2386-2399.
31. Harvey D. Quimica Analitica Moderna 2004, McGraw-Hill, Madrid, Spain.
32. Altria K.D., Rudd D.R. An overview of method validation and system suitability aspects in capillary electrophoresis. Chromatographia 1995, 41:325-331.
33. Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. Validation des procédures analytiques quantitatives, Harmonisation des démarches, S.T.P. Pharma Pratiques 2003, 13:101-138.
34. Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.-A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. Harmonization of strategies for the validation of quantitative analytical procedures. A SFTP Proposal-Part 1. J. Pharm. Biomed. Anal. 2004, 36:579-586.
35. Pharmaceutical Security Institute, The Counterfeit Medicines Challenge, http://www.psi-inc.org/index.cfm.
36. Rohrbasser C., Rhême D., Décastel S., Roth S., de Lourdes Aja Montes M., Veuthey J.-L., Rudaz S. A new capillary electrophoresis device with deep UV detector based on LED technology. Chimia 2009, 63:890-891.
37. C. Rohrbasser, D. Rhême, S. Décastel, S. Roth, J.-L. Veuthey, S. Rudaz, A new deep UV detector for capillary electrophoresis based on LED technology, Unpublished report, 2008.
38. Altria K.D. Long term analysis with capillary electrophoresis. LC-GC Europe 2002, 1:1-5.
39. Liu H.-Y., Ding W.-H. Determination of homologues of quaternary ammonium surfactants by capillary electrophoresis using indirect UV detection. J. Chromatogr. A 2004, 1025:303-312.
40. Marini R.D., Servais A.-C., Rozet E., Chiap P., Boulanger B., Rudaz S., Crommen J., Hubert Ph., Fillet M. Nonaqueous capillary electrophoresis method for the enantiomeric purity determination of S-timolol using heptakis(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin: validation using the accuracy profile strategy and estimation of uncertainty. J. Chromatogr. A 2006, 1120:102-111.
41. Marini R.D., Chiap P., Boulanger B., Rudaz S., Rozet E., Crommen J., Hubert Ph. LC method for the determination of R-timolol in S-timolol maleate: validation of its ability to quantify and uncertainty assessment. Talanta 2006, 68:1166-1175.
42. Mee R. β-expectation and β-content tolerance limits for balanced one-way ANOVA random model. Technometrics 1984, 26:251-253.
43. Feinberg M., Boulanger B., Dewé W., Hubert Ph. New advances in method validation and measurement uncertainty aimed at improving the quality of chemical data. Anal. Bioanal. Chem. 2004, 380:502-514.
44. Bouabidi A., Rozet E., Fillet M., Ziemons E., Chapuzet E., Mertens B., Klinkenberg R., Ceccato A., Talbi M., Streel B., Bouklouze A., Boulanger B., Hubert Ph. Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept. J. Chromatogr. A 2010, 1217:3180-3192.
45. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, Geneva 2005.
46. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 307-310.
47. Dewé W., Govaerts B., Boulanger B., Rozet E., Chiap P., Hubert Ph. Using total error as decision criterion in analytical method transfer. Chemometr. Intell. Lab. Syst. 2007, 85:262-268.